Barclays’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
450,501
-258,465
| -36% | -$597K | ﹤0.01% | 2637 |
|
|
2025
Q1 | $985K | Buy |
708,966
+373,728
| +111% | +$519K | ﹤0.01% | 2456 |
|
|
2024
Q4 | $587K | Buy |
335,238
+87,958
| +36% | +$154K | ﹤0.01% | 2959 |
|
|
2024
Q3 | $513K | Buy |
247,280
+193,046
| +356% | +$400K | ﹤0.01% | 2979 |
|
|
2024
Q2 | $118K | Buy |
+54,234
| New | +$118K | ﹤0.01% | 3301 |
|
|
2023
Q1 | – | Sell |
-44,013
| Closed | -$97K | – | 4420 |
|
|
2022
Q4 | $97K | Sell |
44,013
-3,866
| -8% | -$8.52K | ﹤0.01% | 3479 |
|
|
2022
Q3 | $97K | Hold |
47,879
| – | – | ﹤0.01% | 3430 |
|
|
2022
Q2 | $184K | Buy |
47,879
+3,492
| +8% | +$13.4K | ﹤0.01% | 3180 |
|
|
2022
Q1 | $273K | Buy |
+44,387
| New | +$273K | ﹤0.01% | 3141 |
|